Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
598503
Reference Type
Journal Article
Title
Amitriptyline attenuates interstitial inflammation and ameliorates the progression of renal fibrosis
Author(s)
Achar, E; Maciel, TT; Collares, CF; Teixeira, VPC; Schor, N
Year
2009
Is Peer Reviewed?
1
Journal
Kidney International
ISSN:
0085-2538
EISSN:
1523-1755
Volume
75
Issue
6
Page Numbers
596-604
Abstract
Amitriptyline is a pleiotropic tricyclic antidepressant, which has anti-oxidant and anti-inflammatory properties. We tested whether amitriptyline might be useful in the treatment of chronic renal disease using the mouse model of unilateral ureteral obstruction. Amitriptyline caused a significant reduction of interstitial fibrosis, determined by Masson's staining, with minimal myofibroblast formation and macrophage infiltration following ureteral obstruction. Using quantitative PCR we found that this treatment significantly reduced the expression of key molecular markers of progressive tubulointerstitial injury such as osteopontin, MCP-1, ICAM-1, and TGF-β1 compared to their level in a saline-treated control group. Sublethal X-irradiation or mycophenolate mofetil, treatments that reduce inflammation, were comparable to amitriptyline in the reduction of interstitial fibrosis and macrophage infiltration. These studies in animals suggest that amitriptyline is worth testing as a therapeutic agent that might preserve renal function by blocking inflammation and renal fibrosis.Kidney International (2009) 75, 596–604; doi:10.1038/ki.2008.578; published online 26 November 2008 [ABSTRACT FROM AUTHOR] Copyright of Kidney International is the property of Nature Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts)
Keywords
CELL adhesion molecules; KIDNEYS -- Diseases; CHRONIC renal failure; MYOFIBROBLASTS; FIBROBLASTS; amitriptyline; inflammation; tubulointerstitial fibrosis; unilateral ureteral obstruction
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity